Joshua Brody, MD
img_Joshua Brody
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
ASSOCIATE PROFESSOR | Oncological Sciences
ASSOCIATE PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Internal Medicine, Cancer (Oncology)
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]

BA, Harvard University

MD, State University of NY at Stony Brook School of Medicine

MD, State University of New York Stony Brook School of Medicine

Residency, Internal Medicine, Yale New Haven Hospital

Fellowship, Medical Oncology, Stanford University School of Medicine

Certifications

American Board of Internal Medicine

2011

Society for Immunotherapy of Cancer Presidential Award (SITC 26th Annual Meeting)

2011

SCL Award for top abstract submitted to 2011 International Conference on Malignant Lymphoma

Swiss Cancer League

2011

ASCO Merit Award for top 100 abstracts submitted to 2011 Annual Meeting

American Society of Clinical Oncology

2009

Howard Temin Pathway to Independence Award in Cancer Research (K99/R00) – [1 K99 CA140728-01] ”Immunotransplant to Treat Lymphoma” – 09/09 – 08/14

NCI

2009

‘Outstanding Recent Graduate’

SUNY Stony Brook School of Medicine

2008

ASCO Bradley Stuart Beller Foundation Fellowship Merit Award for best abstract submitted to 2008 Annual Meeting

American Society of Clinical Oncology

2008

William Guy Forbeck Scholar Award – invited to present at 2008 Forum

William Guy Forbeck Research Foundation

2008

MCLC featured researcher

Mantle Cell Lymphoma Consortium

Publications

Selected Publications

Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation. Xucheng Hou, Chang Wang, Yichen Zhong, Leiming Wang, Diana D. Kang, Gabrielle Lubitz, Yonger Xue, Zhengwei Liu, Siyu Wang, Haoyuan Li, Meng Tian, Dinglingge Cao, Kaiyuan Guo, Binbin Deng, David W. McComb, Thomas U. Marron, Brian D. Brown, Miriam Merad, Joshua D. Brody, Yizhou Dong. Journal of Controlled Release

A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities. Danilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, Nikita Kotlov, Maria Sorokina, Jude Phillip, Paul Zumbo, Liron Yoffe, Paola Ghione, Anqi Wang, Xueshuai Han, Abigail Taylor, William Chiu, Valentina Fragliasso, Fabrizio Tabbo, Nahuel Zamponi, Nicolás Di Siervi, Clarisse Kayembe, Giovanni Medico, Ruchi P. Patel, Marcello Gaudiano, Rodolfo Machiorlatti, Giuseppina Astone, Maria Teresa Cacciapuoti, Giorgia Zanetti, Claudia Pignataro, Ruiz Arvin Eric, Sanjay Patel, Francesca Zammarchi, Claudio Zanettini, Lucio Queiroz, Anastasia Nikitina, Olga Kudryashova, Anton Karelin, Daniil Nikitin, Dmitry Tychinin, Ekaterina Postovalova, Alexander Bagaev, Viktor Svekolkin, Ekaterina Belova, Katerina Tikhonova, Sandrine Degryse, Chengqi Xu, Domenico Novero, Maurilio Ponzoni, Enrico Tiacci, Brunangelo Falini, Joo Song, Inna Khodos, Elisa De Stanchina, Gabriele Macari, Luciana Cafforio, Simone Gardini, Roberto Piva, Enzo Medico, Samuel Y. Ng, Allison Moskowitz, Zachary Epstein, Andrew Intlekofer, Dogan Ahmed, Wing C. Chan, Peter Martin, Jia Ruan, Francesco Bertoni, Robin Foà, Joshua D. Brody, David M. Weinstock, Jaspreet Osan, Laura Santambrogio, Oliver Elemento, Doron Betel, Wayne Tam, Marco Ruella, Leandro Cerchietti, Raul Rabadan, Steven Horwitz, Giorgio Inghirami. Cell Reports Medicine

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial. Joshua D. Brody, Judit Jørgensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David John Lewis, Yasmin H. Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Aqeel Abbas, Liwei Wang, Malene Risum, Raul Cordoba. Blood

View All Publications

Joshua Brody, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Brody during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Bristol-Myers Squibb
  • Genentech, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Seattle Genetics
  • Acerta Pharma
  • Kite-Gilead

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.